Fulford (India) raises Rs 40.25 crore

Fulford (India) has raised Rs 40.25 crore by issuing 7,00,000 equity shares of Rs 10 each at a premium of Rs 565 per share, to its promoters Dashtag. The funds were raised to provide capital in order to permit the company to strengthen its position in the market and act on strategic business growth opportunities. Further, the above amount is presently unutilized in respect of the aforementioned purposes and is invested in fixed deposits with various banks.

Fulford (India) is engaged in the business of manufacturing and marketing pharmaceutical consumer products, including cough tablets and herbal ointments, marketed under the trademarks - PEPS and ZAMBUK respectively. It offers medicines for the treatment of allergy and respiratory, arthritis and immunology, cancer therapies, cardiovascular, hepatitis, sun care, etc.